ORYN THERAPEUTICS, Inc.
Young Sohn is a seasoned executive with extensive experience in the technology and software industries. As the Founder and a member of the Board of Directors at Vlocity, Inc. since January 2014, Young has contributed to the development of industry-specific cloud applications on the Force.com and Salesforce1 Platform. In addition, Young co-founded Veeva Systems in January 2007 and has served as a Board member for both Veeva Systems and NOA Bank during the same period. Previous roles include General Manager of Life Sciences at Siebel Systems and Founder and CEO of Nomadic Systems. Young began a career at Oracle as an Area Manager from 1985 to 1991. Young holds a degree from Cornell University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ORYN THERAPEUTICS, Inc.
Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary drug candidates are engineered, stable, cyclic peptides with very low immunogenicity and toxicity. They modulate pathologic inflammation and have proven effective in animal models of autoimmune and chronic inflammatory diseases such as rheumatoid arthritis and ulcerative colitis. They have proven effective in preclinical cancer models and augment natural host defense, functioning as host-directed anti-infectives against drug resistant pathogens.